MAPT and Alzheimer disease: Recent studies have revealed that mTOR activation may be responsible for the breakdown of the blood-brain barrier in AD, the hyperphosphorylation of tau protein, and the persistent metabolic dysfunction associated with the formation of senile plaques (Stanciu et al.